Tuo Jin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Tuo Jin has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Fei Wu
School of Pharmacy Shanghai Jiao Tong University 800 Dongchuan Road Shanghai 200240 China
1 shared publicationGuorong Fan
School of Pharmacy, Second Military Medical University of PLA 325 Guohe Road Shanghai 200433 China
1 shared publicationHua Zhu
Department of Microbiology and Molecular Genetics Rutgers University New Jersey Medical School Newark NJ 07101 USA
1 shared publicationJianguo Liu
School of Pharmacy, Second Military Medical University of PLA 325 Guohe Road Shanghai 200433 China
1 shared publicationSixing Yang
School of Pharmacy Shanghai Jiao Tong University 800 Dongchuan Road Shanghai 200240 China
1 shared publicationWilliam Welsh
Department of Pharmacology Rutgers University Robert Wood Johnson Medical School 661 Hoes Lane West Piscataway NJ 08854 USA
1 shared publication
Latest Publications
- 18 June 2015
- Published by Wiley in Advanced Functional Materials
- Vol. 25 (29) , 4633-4641
Phase‐Transition Microneedle Patches for Efficient and Accurate Transdermal Delivery of Insulin
Utilizing the unique virtue of polyvinyl alcohol (PVA) of forming microcrystalline domains as the cross‐linking junctions, a new microneedle system, phase‐transition microneedle (PTM) patch, is invented, which enables highly efficient transdermal delivery of insulin without depositing the needle tip materials to the skin. PTM, formed of biocompatible PVA as the main component, is sufficiently strong for its needle tip to penetrate the epidermis in the dry state, release preloaded cargos by absorbing body fluid in the dermis layer nearly as fast as subcutaneous injection, and retain mechanical toughness in the hydrated state to ensure complete removal from the skin. The microcrystalline cross‐linking enables a protein‐friendly fabrication process free of hazardous cross‐linking agents required for chemical and ionic cross‐linking. Pharmacokinetic and efficacy studies of insulin‐loaded PTM using pig models indicate a transdermal bioavailability over 20%, similar deviations and peak width, only 18 min behind Tmax, and lower glycated hemoglobin (HbA1c) as compared with injection pens. The complete removability of hydrated needle tips may endow PTM with an additional safety insurance, terminating medication whenever hypoglycemia becomes a concern. PTM patch is practically applicable to a variety of protein/peptide medicines requiring frequent dosing by offering painless administration, freedom of refrigeration, and minimal safety concerns.
- 18 June 2015
- Published by Wiley in Advanced Functional Materials
- Vol. 25 (29) , 4633-4641
Phase‐Transition Microneedle Patches for Efficient and Accurate Transdermal Delivery of Insulin
Utilizing the unique virtue of polyvinyl alcohol (PVA) of forming microcrystalline domains as the cross‐linking junctions, a new microneedle system, phase‐transition microneedle (PTM) patch, is invented, which enables highly efficient transdermal delivery of insulin without depositing the needle tip materials to the skin. PTM, formed of biocompatible PVA as the main component, is sufficiently strong for its needle tip to penetrate the epidermis in the dry state, release preloaded cargos by absorbing body fluid in the dermis layer nearly as fast as subcutaneous injection, and retain mechanical toughness in the hydrated state to ensure complete removal from the skin. The microcrystalline cross‐linking enables a protein‐friendly fabrication process free of hazardous cross‐linking agents required for chemical and ionic cross‐linking. Pharmacokinetic and efficacy studies of insulin‐loaded PTM using pig models indicate a transdermal bioavailability over 20%, similar deviations and peak width, only 18 min behind Tmax, and lower glycated hemoglobin (HbA1c) as compared with injection pens. The complete removability of hydrated needle tips may endow PTM with an additional safety insurance, terminating medication whenever hypoglycemia becomes a concern. PTM patch is practically applicable to a variety of protein/peptide medicines requiring frequent dosing by offering painless administration, freedom of refrigeration, and minimal safety concerns.